Bactericidal, Nonthrombogenic Intravascular Catheters
杀菌、不形成血栓的血管内导管
基本信息
- 批准号:9119055
- 负责人:
- 金额:$ 68.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-01 至 2019-07-31
- 项目状态:已结题
- 来源:
- 关键词:AdhesionsAdverse effectsAnimal ExperimentsAnimal ModelAnimal TestingAnti-Bacterial AgentsAntisepsisAntiviral AgentsBacterial InfectionsBiomedical EngineeringBlood PlateletsBlood-Borne PathogensCathetersChemistryChronicClinicalClinical TrialsCoagulation ProcessDevelopmentDevicesEffectivenessEndotheliumEthylene OxideEvaluationExtracorporeal CirculationGenerationsGoalsGrantHealthHeatingHourIn VitroInfectionInfection preventionKlebsiella pneumonia bacteriumLaboratoriesLaboratory AnimalsMeasuresMedicalMethodsMicrobeMicrobial BiofilmsModelingN-acetylpenicillamineNitric OxideNitric Oxide DonorsOryctolagus cuniculusPatientsPhysiologicalPolymersPolyurethanesPreparationPreventionProblem SolvingProgress ReportsPropertyPseudomonas aeruginosaPublic Health SchoolsResearchResearch Project GrantsS-NitrosothiolsSheepSiliconesSinusSolventsStaphylococcus aureusStaphylococcus epidermidisSterilizationSurfaceSwellingTechnologyTemperatureTestingThrombosisTimeToxic effectTranslationsantimicrobialantimicrobial drugbactericidebaseclinical applicationcommercial applicationcostcost effectivediazeniumdiolateimplanted sensorin vivokillingsmacrophagenatural antimicrobialneutrophilnovelnovel strategiesphysical propertypreventresearch studyscreening
项目摘要
DESCRIPTION: Infection and thrombosis on intravascular catheters are major, expensive problems in medical practice. Over the last ten years we have demonstrated that surface nitric oxide (NO) release can solve these problems, using various NO donor molecules (e.g., diazeniumdiolates, S-nitrosothiols (RSNOs)) incorporated into polymeric catheter tubing. This technology is based on the fact that NO released within the sinus cavities and by neutrophils and macrophages functions as a potent natural antimicrobial and antiviral agent. Further, NO secretion by the normal endothelium prevents clotting by preventing platelet adhesion and activation. We have developed polymers that continuously produce NO to prevent biofilm formation, platelet adhesion, and thrombosis in relevant animal models of intravascular catheters. Although effective, the cost, toxicity, and preparation of the donor molecules used to date have prevented clinical application. We have recently discovered that all of the positive effects of NO release can be achieved with the NO donor molecule S-nitroso-N-acetylpenicillamine (SNAP). In contrast to earlier NO release materials, polymers that are doped/impregnated with SNAP are easy to fabricate, nontoxic, inexpensive, and very stable. We will develop new methods of fabricating NO release catheters with polymer stabilized SNAP (e.g., solvent impregnation, NO releasing multilumen catheters, etc.). The chemistry laboratory directed by Dr. Meyerhoff will create and evaluate combinations of SNAP loaded into polyurethane and silicone catheters, optimize NO release rates for 21 d, reduce leaching rates, enhance durability, and demonstrate the ability to sterilize without significant loss in NO loading Dr. Bull, a bioengineer, will model NO release from certain multi-lumen catheter configurations and also oversee testing of the physical properties of the catheters (e.g., durometer, surface roughness, etc.), in terms of potential changes in such parameters as a result of SNAP impregnation. Dr. Xi's laboratory in the School of Public Health, will examine the antimicrobial/antibiofilm activity of the new NO release catheters against several microbes known to be associated with infections caused by intravascular catheters in hospitalized patients. The large animal laboratory, directed by Dr. Bartlett, will evaluate the optimized NO secreting catheters in chronic animal testing to evaluate effect on biofilm and thrombosis formation. This bioengineering research grant (BRG) combines new basic chemistry of RSNO-based NO release agents in biomedical polymers, the bioengineering to use this chemistry to make practical devices, the microbiological studies to prove effectiveness against targeted bacterial strains, and biologic evaluation in animal models, all leading to clinical translation in
four years.
描述:血管内导管的感染和血栓形成是医疗实践中主要的、昂贵的问题。在过去的十年中,我们已经证明,表面一氧化氮(NO)释放可以解决这些问题,使用各种NO供体分子(例如,二醇二氮烯鎓、S-亚硝基硫醇(RSNO))。该技术基于这样的事实,即在窦腔内以及由中性粒细胞和巨噬细胞释放的NO用作有效的天然抗微生物剂和抗病毒剂。此外,正常内皮的NO分泌通过防止血小板粘附和活化来防止凝血。我们已经开发了连续产生NO的聚合物,以防止血管内导管的相关动物模型中的生物膜形成、血小板粘附和血栓形成。尽管有效,但迄今为止使用的供体分子的成本、毒性和制备阻碍了临床应用。我们最近发现,NO释放的所有积极作用都可以通过NO供体分子S-亚硝基-N-乙酰青霉胺(SNAP)实现。与早期的NO释放材料相比,用SNAP掺杂/浸渍的聚合物易于制造、无毒、便宜且非常稳定。我们将开发制造具有聚合物稳定的SNAP的NO释放导管的新方法(例如,溶剂浸渍、NO释放多腔导管等)。由Meyerhoff博士指导的化学实验室将创建和评估加载到聚氨酯和硅胶导管中的SNAP组合,优化21 d的NO释放速率,降低浸出率,增强耐久性,并证明在NO加载无显著损失的情况下灭菌的能力。将对某些多腔导管配置的NO释放进行建模,并监督导管物理性能的测试(例如,硬度计、表面粗糙度等),就SNAP浸渍导致的这些参数的潜在变化而言。Xi博士在公共卫生学院的实验室将检查新型NO释放导管对已知与住院患者血管内导管引起的感染有关的几种微生物的抗菌/抗菌膜活性。由Bartlett博士指导的大型动物实验室将在慢性动物试验中评价优化的NO分泌导管,以评价对生物膜和血栓形成的影响。这项生物工程研究资助(BRG)结合了生物医学聚合物中基于RSNO的NO释放剂的新基础化学,使用这种化学物质制造实用设备的生物工程,证明对目标细菌菌株有效性的微生物学研究,以及动物模型中的生物学评估,所有这些都导致了临床转化。
四年
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert H. Bartlett其他文献
Extracorporeal Life Support Organization 1993.
体外生命支持组织 1993。
- DOI:
- 发表时间:
1993 - 期刊:
- 影响因子:0
- 作者:
C. J. Stolar;Thomas Delosh;Robert H. Bartlett - 通讯作者:
Robert H. Bartlett
Extracorporeal life support for status asthmaticus.
哮喘持续状态的体外生命支持。
- DOI:
- 发表时间:
1993 - 期刊:
- 影响因子:9.6
- 作者:
Michael B. Shapiro;Andrew C. Kleaveland;Robert H. Bartlett - 通讯作者:
Robert H. Bartlett
The Artificial Placenta Rescues Premature Lambs from Ventilatory Failure
- DOI:
10.1016/j.jamcollsurg.2017.07.354 - 发表时间:
2017-10-01 - 期刊:
- 影响因子:
- 作者:
Joseph T. Church;Jennifer S. McLeod;Elena M. Perkins;Robert H. Bartlett;George B. Mychaliska - 通讯作者:
George B. Mychaliska
Twenty-Four Hour Normothermic Ex Vivo Heart Perfusion With Hemofiltration In an Adult Porcine Model
- DOI:
10.1016/j.transproceed.2023.08.014 - 发表时间:
2023-11-01 - 期刊:
- 影响因子:
- 作者:
Brianna L. Spencer;Spencer K. Wilhelm;Kristopher A. Urrea;Vikramjit Chakrabortty;Sebastian J. Sewera;Daniel E. Mazur;Robert H. Bartlett;Alvaro Rojas-Peña;Daniel H. Drake - 通讯作者:
Daniel H. Drake
Development of a membrane oxygenator: overcoming blood diffusiolimitation.
膜氧合器的开发:克服血液扩散限制。
- DOI:
10.1016/s0022-5223(19)42526-9 - 发表时间:
1969 - 期刊:
- 影响因子:0
- 作者:
Robert H. Bartlett;Diane Kittredge;Bertram S. Noyes;Ralph H. Willard;Philip A. Drinker;Dwight E. Harken - 通讯作者:
Dwight E. Harken
Robert H. Bartlett的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert H. Bartlett', 18)}}的其他基金
Research Supplement to Promote Diversity Supplement for the ECMO without Anticoagulation
研究补充促进无抗凝 ECMO 的多样性补充
- 批准号:
10712181 - 财政年份:2023
- 资助金额:
$ 68.99万 - 项目类别:
Low Cost Electrochemical Gas Phase Nitric Oxide Generator for Biomedical Applications
用于生物医学应用的低成本电化学气相一氧化氮发生器
- 批准号:
10026450 - 财政年份:2019
- 资助金额:
$ 68.99万 - 项目类别:
Low Cost Electrochemical Gas Phase Nitric Oxide Generator for Biomedical Applications
用于生物医学应用的低成本电化学气相一氧化氮发生器
- 批准号:
10328221 - 财政年份:2019
- 资助金额:
$ 68.99万 - 项目类别:
Electrochemical Generation of Nitric Oxide for Gas Phase Biomedical Applications
用于气相生物医学应用的电化学生成一氧化氮
- 批准号:
9243306 - 财政年份:2016
- 资助金额:
$ 68.99万 - 项目类别:
Extracorporeal CPR for Refractory Out-of-Hospital Cardiac Arrest (EROCA) Trial Planning Grant
难治性院外心脏骤停 (EROCA) 体外心肺复苏 (EROCA) 试验计划补助金
- 批准号:
9182635 - 财政年份:2016
- 资助金额:
$ 68.99万 - 项目类别:
Bactericidal, Nonthrombogenic Intravascular Catheters
杀菌、不形成血栓的血管内导管
- 批准号:
9316710 - 财政年份:2015
- 资助金额:
$ 68.99万 - 项目类别:
Combined Nitric Oxide Release and Argatroban for Thromboresistant Coatings
结合一氧化氮释放和阿加曲班用于抗血栓涂层
- 批准号:
8692758 - 财政年份:2013
- 资助金额:
$ 68.99万 - 项目类别:
Combined Nitric Oxide Release and Argatroban for Thromboresistant Coatings
结合一氧化氮释放和阿加曲班用于抗血栓涂层
- 批准号:
8580797 - 财政年份:2013
- 资助金额:
$ 68.99万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 68.99万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 68.99万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 68.99万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 68.99万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 68.99万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 68.99万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 68.99万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 68.99万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 68.99万 - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
$ 68.99万 - 项目类别:
Discovery Grants Program - Individual